SCA
HAO icon

Sassicaia Capital Advisers’s Haoxi Health Technology Ltd HAO Stock Holding History

Sassicaia Capital Advisers’s Portfolio HAO Stock Details HAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$1.5K – 33
2024
Q4 		$1.5K Buy
+3
New +$1.71K 0.04% 7

Other funds holding HAO

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sassicaia Capital Advisers's HAO Position: Q1 2025 in Review

Sassicaia Capital Advisers sold out of Haoxi Health Technology Ltd (HAO) in Q1 2025, closing a stake of 3 shares — an estimated $1.5K sold.

Sassicaia Capital Advisers first reported a position in HAO in Q4 2024 and held it in 1 quarter. The position peaked at $1.5K in Q4 2024. 5 funds tracked by Wall St. Rank hold HAO as of Q1 2025.

  • Sassicaia Capital Advisers reported no remaining Haoxi Health Technology Ltd position as of Q1 2025 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 3 Haoxi Health Technology Ltd shares in Q1 2025, an estimated $1.5K.
  • Sassicaia Capital Advisers first reported a position in Haoxi Health Technology Ltd in Q4 2024 and held it in 1 quarter.
  • Sassicaia Capital Advisers's Haoxi Health Technology Ltd position peaked at $1.5K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q1 2025.

Based on Sassicaia Capital Advisers's 13F filing for Q1 2025, filed 15 May 2025.